MagiMagdiKhalilMDPhD

PubMed

• 47 citations
  Anti-CD40 agonist antibodies: preclinical and clinical experience
  Magi Khalil, Robert H. Vonderheide> ;Update on Cancer Therapeutics. 2007 Jun 1
• 21 citations
  The naive B cell repertoire predisposes to antigen-induced systemic lupus erythematosus.
  Chuansheng Wang, Magi Khalil, Jeffrey V. Ravetch, Betty Diamond> ;Journal of Immunology. 2003 May 1
• 35 citations
  T Cell Studies in a Peptide-Induced Model of Systemic Lupus Erythematosus
  Magi Khalil, Kayo Inaba, Ralph M. Steinman, Jeffrey V. Ravetch, Betty Diamond> ;Journal of Immunology. 2001 Feb 1

Journal Articles

• Tremelimumab in combination with exemestane in patients with advanced breast cancer and treatment-associated modulation of inducible costimulator expression on patient...  
  Vonderheide, R.H., LoRusso, P.M., Khalil, M., Gartner, E.M., Khaira, D., Soulieres, D., Dorazio, P., Trosko, J.A., Rüter, J., Mariani, G.L., Usari, T., Domchek, S.M., Clin Cancer Res, 1/1/2010
• Increased IL-12 inhibits B cells' differentiation to germinal center cells and promotes differentiation to short-lived plasmablasts  
  Kim, S.J., Caton, M., Wang, C., Khalil, M., Zhou, Z., Hardin, J., and Diamond, B., J. of Exp. Med., 1/1/2008
• Clinical Activity and Immune Modulation in Cancer Patients Treated with CP-870,893, A Novel CD40 Agonist Monoclonal Antibody  
  Vonderheide, R.H., Flaherty, K.T., Khalil, M., Schachter, M.S., Bajor, M., Gallagher, M., Sullivan, P., Mahaney, J.J., O’Dwyer, P., Huhn, R.D., and Antonia, S.J., J. Clin. Onc., 1/1/2007
• Anti-CD40 agonist antibodies: Preclinical and clinical experience  
  Khalil, M. and Vonderheide, R.H., Update on Cancer Therapeutics, 1/1/2007
• The Naive B Cell Repertoire Predisposes to Antigen-Induced Systemic Lupus Erythematosus  
  Wang, C., Khalil, M. (co-authors), Ravetch, J. and Diamond, B., J. Immunol, 1/1/2003
• T Cell Studies in a Peptide-Induced Model of Systemic Lupus Erythematosus  
  Khalil, M., Inaba, K., Steinman, R., Ravetch, J. and Diamond, B., J. Immunol, 1/1/2001
• Psoralen Damage-Induced Recombination in Saccharomyces cerevisiae: Dependence on RAD1 and RAD52  
  Saffran, W.A., Cantor, C.R., Smith, E.D. and Magdi, M., Mutation Research, 1/1/1992
• Join now to see all

Books/Book Chapters

• Systemic Lupus Erythematosus. 
  Chapter: Anti-DNA Antibodies. 
  Page 197 - 217Khalil, M., Spatz, L. and Diamond, B.Editors: Lahita, R.G..Academic Press, Inc., New YorkEdition 3rd,1999
• Immunological Techniques Made Easy 
  Chapter: Protocol 81: Immune Complexes Detection. 
  Page 246 - 248Khalil, M. and Diamond, B.Editors: Cochet, O., Teillaud, J.L. and Sautes, C..Wiley & Sons, Inc., New York1998

Abstracts/Posters

• Tremelimumab in combination with exemestane as novel immunotherapy for patients with advanced breast cancer.
  Vonderheide, R.H., LoRusso, P.M., Khalil, M., Heath, E., Khaira, D., Soulieres, D., Dorazio, P., Mariani, G.L., Usari, T., and Domchek, S.M., Annual Meeting of the American Society of Clinical Oncology (ASCO), Orlando, FL, 5/29/2009
• “The Role of EGFR in the Prognosis and Treatment of NSCLC”
  Khalil MM, MSKCC Junior Faculty Conference, Basking Ridge, NJ, 12/16/2008
• “Clinical Activity and Immune Modulation in Cancer Patients Treated with a Novel CD40 Agonist Monoclonal Antibody”
  Khalil MM, UNC Lineberger Comprehensive Cancer Center, Chapel Hill, NC, 12/18/2006
• “Antigen Presenting Cell Activation and Clinical Activity of an Anti-CD40 Agonist Antibody”
  Khalil MM, The Eunice and Irving Leopold Annual Scientific Symposium and Retreat, Philadelphia, PA, 3/9/2005
• "Cellular Interactions in a Peptide-Induced Model of Systemic Lupus Erythematosus”
  Khalil MM, MSTP Summer Seminar Series, Bronx, NY, 9/13/2000
• “T Cell Studies in a Peptide-Induced Model of Systemic Lupus Erythematosus”
  Khalil MM, Microbiology and Immunology Student Invited Speaker Presentations, Bronx, NY, 4/15/1999
• “Genetic Susceptibility and Environment Triggers for Anti-DNA Antibody Production”
  Khalil MM, 2nd International Congress on Autoimmunity, Tel Aviv, Israel, 3/7/1999
• "Analysis of a Peptide-Induced Model of Systemic Lupus Erythematosus”
  Khalil MM, Keystone Symposia on Molecular and Cellular Biology: B lymphocyte Biology and Disease, Taos, NM, 2/8/1999
• “The Role of Fc Receptors in the Anti-dsDNA Immune Response”
  Khalil MM, Medical Scientist Training Program Retreat, New Paltz, NY, 10/18/1998
• Join now to see all

Lectures

• “Clinical Activity and Immune Modulation in Cancer Patients Treated with a Novel CD40 Agonist Monoclonal Antibody” - Medicine Grand Rounds 
  Penn State Milton S. Hershey Medical Center, Hershey, PA - 11/9/2006